New development of Immune checkpoints blockade in cancer immunotherapy
Immunotherapy has become the main stream in cancer treatment nowadays. It includes T cell, NK cell targeted therapy, as well as antibody targeted therapy and its derivatives. Recently immune checkpoints blockade (ICB) has been developed, which are said to be a better method in treatment. The release...
Main Author: | Wu Feixuan |
---|---|
Format: | Article |
Language: | English |
Published: |
EDP Sciences
2019-01-01
|
Series: | E3S Web of Conferences |
Online Access: | https://www.e3s-conferences.org/articles/e3sconf/pdf/2019/57/e3sconf_chinabiofilms18_01022.pdf |
Similar Items
-
CANCER IMMUNOTHERAPY BASED ON THE BLOCKADE OF IMMUNE CHECKPOINTS
by: A. V. Bogolyubova, et al.
Published: (2015-10-01) -
Immune-Checkpoint Blockade and Active Immunotherapy for Glioma
by: Brian J. Ahn, et al.
Published: (2013-11-01) -
Targeting MDSC for Immune-Checkpoint Blockade in Cancer Immunotherapy: Current Progress and New Prospects
by: Tianhang Li, et al.
Published: (2021-08-01) -
Combinatorial blockade for cancer immunotherapy: targeting emerging immune checkpoint receptors
by: Dia Roy, et al.
Published: (2023-10-01) -
Mechanisms underlying response and resistance to immune checkpoint blockade in cancer immunotherapy
by: Junghwa Lee, et al.
Published: (2023-07-01)